Active ingredientRimonabant HClCat. No. P-R063-001CAS 158681-13-1Family · Pharmaceutical analytical standards
Rimonabant
The first selective blocker of the cannabinoid CB1 receptor (an inverse agonist), described in 1994: approved in Europe in 2006 for the treatment of obesity alongside diet and exercise, it remained on the market until 2008. This family brings together the active ingredient and labelled standards.
Did you know?It belongs to the 1,5-diarylpyrazole chemical family; first thought to be CB1-selective, it was later found to block mu opioid receptors as well.
Go to the active ingredient →Active ingredientRimonabant HClCat. No. P-R063-001CAS 158681-13-1
Isotopically labelledRimonabant-d10Cat. No. P-R063-002CAS 929221-88-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.